Show Notes
In Episode 7 of the Skin Flint Podcast we invited Jill Maddison to come chat with us. Jill is Professor of General Practice, Director of Professional Development and Director of the BVetMed course at the Royal Veterinary College (RVC).
Log this CPD with 1CPD here
Show Notes
Introduction (00:00) John introduces the podcast topic, along with producer Paul and Sue Paterson - who introduces us to the topic of compliance as well as the guest, Jill Maddison, the professor of general practice at the Royal Vet College in London who is published on the subject of compliance with a strong practical background. Chapter 1 - Understanding Compliance. (02:53) Jill introduces herself and her specialities in compliance and clinical reasoning and how they meet.
(04:02) Sue asks Jill about the importance of compliance when administering medications and Jill points out it doesn’t matter how carefully the medication is chosen, if the client doesn’t administer it the therapy won’t be effective and this is often taken for granted in veterinary medicine.
(04:49) Sue asks Jill to define complicate and Jill shares that compliance, or adherence as it is often called, is where the owner gives the medication as prescribed, in terms of the frequency, dosage and length of treatment. A client not 100% compliant might miss doses or not finish a course.
(06:06) John then asks Jill to outline some of the issues which could arise from a loss of that compliance. Jills says that therapeutic success is better with closest to 100% compliance, but also with some classes of drugs such as antibiotics, poor compliance could lead to resistance to that drug because the plasma levels drop below the required amount. Then also in a long term treatment regime such as epilepsy there can be poor therapeutic outcome, but also the patient can need more drugs in the long term because they are not managed effectively, which could lead to more side effects. Also with pain management, they could be in more pain as a result of poor management of the pain due to an insufficient level of pain relief. And finally in diseases where the condition goes into remission but the drug should be continued, the client may stop the medication leading to the return or exacerbation of the issue. Jill uses the example of us with a cold for which we do end up on antibiotics, but then we stop them as we start to feel better because we forget to take it them.
Chapter 2 - Recognising Compliance (10:53) - John asks what factors from an owners perspective would halt compliance to a therapy and Jill reflects that allergic skin disease is a very applicable condition to this problem, showing that if an owner doesn’t fully understand the reason for a therapy they may not comply and so more of the treatment may be needed long term, for example if they don’t understand that the disease won’t be cured. Jill points out this all comes down to the relationship between the client and the clinician, as communication is so important. She shares the results of an online survey, and trust was a common theme - with owners least happy with the consultation were the least likely to comply with the medication - with 80% of owners complying well but 20% very poorly and evidence showing these people made their own clinical judgment as a result of a breakdown in that relationship between client and clinician.
(16:39) Sue asks if this relationship is better or worse with a nurse, suggesting that they may find nurses more approachable. Jill says there are studies in human literature to suggest information was better received from nurses, and they were more likely to admit not compliance to a nurse - So Jill feels nurses are very important to this aspect of veterinary care, maintaining that communication and relationship with more dedicated time with the owner.
(19:00) Sue also points out nurses are generally better at speaking in plain English and Jill agrees they are excellent for demonstrating med
More from The Skin Flint Podcast
CHAPTER 1 – Rosanna’s 2 Pennies Worth This month, Sue, John and Paul welcome Rosanna Marsella to the platform - Diplomate of the American College of Veterinary Dermatology and Professor at the University of Florida. 03:57 – John invites Rosanna to introduce herself. Thirty years as a veterinary dermatologist at the University of Florida, teaching, researching and treating small-animal allergy alongside some large-animal work; Florida's climate means plenty of infections. 04:42 – John asks how she'd categorise pyoderma. Rosanna explains it's classified by depth: surface pyoderma (often the "hot spot"), superficial pyoderma (essentially bacterial folliculitis), and deep pyoderma, where infection breaches the follicle wall into the dermis (furunculosis). 05:35 – Sue asks how dysbiosis differs from surface pyoderma. Allergic dogs already have reduced microbiome diversity, which shifts sharply toward Staphylococcus during a flare; dysbiosis is that pre-pustular shift, while surface pyoderma is the acute inflammatory skin-barrier damage that follows. 07:45 – Sue asks what AMD looks like clinically. Rosanna describes the classic picture: thick-coated dogs developing intensely pruritic, erosive lesions almost overnight on the face, rump or hips, driven by an acute trigger plus moisture trapped against the skin. 09:01 – John asks how important it is to find the trigger rather than just treat the lesion. Miss it, Rosanna says, and the dog either won't fully respond or will relapse. 09:54 – John runs through the usual suspects - fleas, allergic skin disease, ear disease, trapped moisture, pain, boredom. Rosanna splits these into predisposing factors (thick coat, heat, humidity, swimming) and primary triggers, ranking fleas top: an oral flea product still needs the flea to bite before it works, so a flea-allergic dog may also need a repellent. 13:37 – Sue asks whether lesion distribution helps distinguish flea-driven AMD from other allergies. Rosanna's rule of thumb: the back half of the body is fleas until proven otherwise; facial lesions warrant a work-up for pollen allergy or Malassezia otitis, both intensely itchy in their own right. 17:07 – John asks Sue whether "fleas first" holds in the UK climate too. Sue agrees fleas should be ruled out in every case, even with fast-acting isoxazoline parasiticides on board. CHAPTER 2 – More Than Skin Deep
In this month's episode, Sue, John and Paul welcome Professor & Chief of Service (Dermatology) at UC Davis, Stephen D White to the podcast. Chapter 1: Sheep Skin Detectives (03:09) Sue sets the scope: primary-care perspective rather than rare autoimmune disease. Stephen confirms autoimmune skin disease is vanishingly rare in sheep (pemphigus foliaceus essentially unreported, bar one Barbary sheep case in a zoo). (06:10) Sue asks whether clinical distribution helps localise the cause in a pruritic sheep the way it does in a dog or cat. Stephen explains it's less reliable — thick wool can mask hair loss even with significant pruritus, though rubbing behaviour is usually evident. Lice are visible with a hand lens; mites are not. (08:07) Question on empirical response to treatment. Stephen notes lice usually respond well to licensed ectoparasiticides (mainly avermectins); isoxazolines are unlicensed in ruminants and unreported in sheep specifically (though used in camelids, and anecdotally a bighorn sheep). Repeat treatment at 2–4 weeks is usually needed to catch hatching eggs. Chapter 2: Suspect Number 1 - Ectoparasites (11:30) John asks for top differentials in a pruritic sheep, Stephen answers: “ectoparasites, ectoparasites, and ectoparasites” — mites, lice and sheep keds (which are insects, not mites). He stresses checking in-contact sheep, since one animal may be subclinical while another is severely affected. (13:49) Sue asks why would a referral centre see an ectoparasite case at all? Stephen: usually a failed or incomplete owner-applied treatment, or a backyard sheep simply not monitored closely enough for early signs. (15:29) On technique: always scrape if pruritic, using a medical-grade spatula rather than a blade (sheep are skittish; a slip with a blade causes injury). An otoscope with the cone removed doubles as a magnifier and light source. Dermatophytosis should also be considered — often presenting as facial alopecia rather than fleece loss — and can coexist with ectoparasitism. (15:09) John ask about photosensitisation. Stephen distinguishes hepatogenous causes (impaired phylloerythrin metabolism from hepatotoxic plants, or a genetic defect in Corriedale lambs) from primary photodynamic plant ingestion (e.g. St John's Wort). Lesions favour the head and distal limbs. Flock-wide cases point to an environmental cause (send hay/pasture samples to the local extension lab); idiosyncratic reactions (as seen with clover in horses) may occur but are poorly documented in ruminants. Chapter 3: Dermatological Movie Stars (26:48) John introduces orf, referencing its cameo in Sheep Detectives. Stephen describes it as a parapoxvirus infection, usually self-limiting, but causing anorexia through oral pain — a problem in production settings. A non-resolving “super orf” form causes severe weight loss. Stephen shares data from the retrospective study: of ten orf-affected sheep, five were euthanised, due to generalised cutaneous lesions or concurrent Corynebacterium pseudotuberculosis abscesses — evidence that orf can significantly compromise immune function. One case of orf-associated facial alopecia resolved fully once the virus cleared. (31:07) On zoonotic risk and management: gloves are essential when handling any crusting lesion in sheep or goats. Management includes moistening hay to ease painful feeding, antibiotics for secondary bacterial infection, and parenteral treatment or stomach tubing in severe anorexia. (33:17) Sue asks about bacterial skin disease. Stephen identifies C. pseudotuberculosis and staphylococcal abscesses as the main presentations — often large, anywhere on the body, commonly peri udder in females. Internal abscessation (lungs, liver) is a key concern; aspirated purulent masses warrant involving a large-animal colleague, with caution against environmental contamination during drainage. Dermatophilosis is discussed as globally widespread and rain-associated, presenting dorsally, or interdigi
In this episode of Skinflints, we are joined by veterinary dermatologist Dr Stephen Shaw to discuss the role of JAK inhibitors in managing canine atopic dermatitis. Stephen explains the underlying disease process, highlighting the key cytokines involved in itch and inflammation, and how JAK inhibitors provide rapid, broad-spectrum control by blocking these signalling pathways. The discussion explores how treatment should be tailored to each individual dog, considering disease severity, secondary infections and long-term management goals. Stephen also explains the benefits of using JAK inhibitors during food trials, their role alongside other therapies, and practical considerations such as monitoring, vaccination and managing concurrent disease. The episode concludes by emphasising the importance of evidence-based treatment, informed owner discussions and regular clinical assessment, reinforcing that successful management relies on selecting the right therapy for each patient rather than adopting a one-size-fits-all approach. This episode is kindly sponsored by MSD Animal Health
(00:00:00) John introduces a new episode on Feline Orofacial Pain Syndrome (FOPS) — a baffling condition where cats can flip from calm to frantic self-injury around the mouth and face in seconds.